Aurobindo Pharma reports US FDA inspection at Auroactive Pharma Srikakulam facility, notes two observations with no impact on financials or operations.
Aurobindo Pharma reports US FDA inspection at Auroactive Pharma Srikakulam facility, notes two observations with no impact on financials or operations.